NADPH is known to be tightly bound to mammalian catalase and to offset the ability of the substrate of catalase (H2O2) to convert the enzyme to an inactive state (compound II). In the process, the bound NADPH becomes NADP+ and is replaced by another molecule of NADPH. This protection is believed to occur through electron tunneling between NADPH on the surface of the catalase and the heme group within the enzyme. The present study provided additional support for the concept of an intermediate state of catalase, through which NADPH serves to prevent the formation (rather than increase the removal) of compound II. In contrast, the superoxide radical seemed to bypass the intermediate state since NADPH had very little ability to prevent the superoxide radical from converting catalase to compound II. Moreover, the rate of NADPH oxidation was several times the rate of compound II formation (in the absence of NADPH) under a variety of conditions. Very little NADPH oxidation occurred when NADPH was exposed to catalase, H2O2, or the superoxide radical separately. That the ratio exceeds 1 suggests that NADPH may protect catalase from oxidative damage through actions broader than merely preventing the formation of compound II.
Interest in the disposal of reactive oxygen species stems from the growing evidence that these molecules are active or participating agents in mutagenesis and aging and in the cellular damage from a wide variety of environmental and endogenous stresses (, ,
3
). One of the more highly studied cells under oxidative stress is the human erythrocyte with, and without, a genetic impairment in maintaining NADP in the reduced state (NADPH) (, 5
, 6
, , 8
, 9
, 10
). The impairment results from the most common of the potentially lethal human enzyme defects, that of glucose-6-phosphate dehydrogenase. The susceptibility of such cells to oxidative stress was initially attributed to the need for NADPH to remove hydrogen peroxide (H2O2) via glutathione reductase and glutathione peroxidase (). Attempts to identify a soluble protein that was binding NADPH within human erythrocytes led to the discovery that one molecule of NADPH is tightly bound to each of the four subunits of catalase (H2O2:H2O2oxidoreductase, EC 1.11.1.6) of mammals (11
). Studies of purified catalase revealed that NADPH effectively protects catalase against H2O2 at physiologically realistic concentrations of both NADPH and H2O2 (12
). These and other findings (13
) with highly purified catalase confirmed studies that led earlier investigators to notice the same effect in hemolysates (14
). This action of NADPH solved a decades-old puzzle as to the nature of reducing equivalents that serve to keep catalase active in vivo. Later studies revealed that, within human erythrocytes, the role of NADPH in keeping catalase active was more important than the role of NADPH in the glutathione reductase/peroxidase pathway (, 8
, 9
, 10
). Evidence has been presented that NADPH protects catalase by preventing and reversing the formation of an inactive form of catalase, compound II, which differs within the heme group from active catalase (12
). Work in over five laboratories has provided information on how NADPH could accomplish this task (12
,15
, , 17
, 18
, , 20
). Among the difficulties in explaining the protection of catalase by NADPH is that NADPH is bound on the surface of catalase, some 20 Å from the heme, that the channel to the heme is too narrow to accommodate NADPH, and that conversion of compound II back to native catalase is a one-electron reduction step, whereas NADPH is traditionally regarded as a two-electron reducing substance. The present study provides kinetic and stoichiometric observations on the mechanism of this action by NADPH and suggests how a current model of this action will need to be revised to accommodate these new findings.An understanding of the experiments that follow requires knowledge of the terminology and pathways for the interconversion of the various forms of catalase. Fig. 1 consists of the additions of Lardinois () to the traditional scheme (
22
) for those interconversions. The role of NADPH in the scheme is described under the “Discussion.” Ferricatalase has a protoporphyrin IX-iron(III) complex as its active site and is the native, free, or resting state of the enzyme. Compound I, which is the other active form of catalase, contains an atom of oxygen gained from step 1 (see Fig. 1 forsteps 1–9), leaving the protoporphyrin-iron group at 2 oxidation equivalents above that of ferricatalase (). The overall conversion of H2O2 to H2O and O2 requires that the enzyme alternate between being ferricatalase and compound I. Compounds II and III are two inactive forms of catalase that can arise from exposure of catalase to either H2O2 (22
) or O⨪2 (). Compound II arises by one-electron reduction of compound I and is considered to be an iron(IV) oxo-ligated porphyrin (23
). The one-electron reduction can result from certain reducing substances of relatively small molecular size, such as ferrocyanide, or from a poorly understood “endogenous donor” within the structure of catalase (17
, 22
). Compound III, also called oxycatalase, is regarded as having similarity to the oxy compounds of myoglobin and hemoglobin (). Although the rate constant for step 2 is much higher than that for step 9, ethanol can be added at a concentration greatly exceeding the steady-state concentration of H2O2 that is generated by glucose oxidase (22
). The resulting severe reduction in concentration of compound I has been used to demonstrate that compound I is a precursor to compound II (22
). Compound III can arise from the action of H2O2on compound II or from the action of O⨪2 on ferricatalase (Fig.1) (). Each state of catalase has its own absorption spectrum, although no single wavelength provides a measurement of just one of the four states. Compounds II and III revert spontaneously to an active form of catalase when H2O2 and O⨪2 are no longer present. Continual presence of some of the catalase as compound II or compound III, however, leads gradually to irreversible inactivation of the enzyme through step 8 ().
Figure 1Reactions and interconversions of the four states of mammalian catalase. Compounds II and III are the inactive states of catalase. DH represents the endogenous donor.
EXPERIMENTAL PROCEDURES
All incubations were with commercially available, extensively purified enzymes. Sigma was the source of the manganese superoxide dismutase from Escherichia coli. As with the studies of Kono and Fridovich (
23
), manganese superoxide dismutase was used for most of this study because, unlike Cu,Zn superoxide dismutase, it is not inactivated by H2O2. Roche Molecular Biochemicals (Mannheim, Germany) was the source of catalase from bovine liver, xanthine oxidase from bovine milk, Cu,Zn superoxide dismutase from bovine erythrocytes, glucose oxidase from Apergillus niger, and glucose-6-phosphate dehydrogenase from yeast. The buffer used for most of this study was 0.1 mm EDTA, 50 mmNa2HPO4-KH2PO4 buffer, pH 7.4 (Na-K phosphate buffer). A second buffer was KR-Tes,
which is a Krebs-Ringer/Tes solution containing, in the following final millimolar concentrations: NaCl 119; KCl 4.7; CaCl2 2.5; KH2PO4 1.2; MgSO4 1.2; and (sodium) Tes, pH 7.4, 22.6. Crystalline bovine liver catalase was dissolved in KR-Tes, concentrated on CF-25 ultrafiltration cones (Amicon), and then washed on the cones (12
) with the buffer to be used in each experiment. All other enzymes were both dissolved and washed with the buffer to be used in each experiment.The solution of each enzyme was assayed for protein concentration (
24
) and activity. The activity of catalase was determined from the first-order rate constant of the rate of disappearance of H2O2, at an initial concentration of 10 mm, as measured by absorbance at 240 nm with a recording spectrophotometer (). By this assay, the bovine liver catalase had an activity of 23.7 s−1 per micromolar catalase concentration (5.9 s−1 per micromolar heme concentration). The rate of formation of H2O2 by glucose oxidase in the presence of 5 mm glucose was determined with the assay for H2O2 of Green and Hill (). The glucose oxidase catalyzed the generation of H2O2 at an average rate of 2,100 μmol min−1 per μmol of glucose oxidase. The rate of generation of O⨪2 by xanthine oxidase in the presence of xanthine (100 μm) was measured in 50 mm Na-K phosphate buffer, pH 7.4, by the rate of reduction of ferricytochrome c (10 μm) at 550 nm, using the extinction coefficient at 550 nm of 21,000m−1 cm−1, according to the method of McCord and Fridovich (27
). The replotting method of Sawada and Yamazaki (28
) provided assurance that the spontaneous dismutation reaction was second-order with respect to O⨪2 and revealed a value of 9.14 × 10−4m s fork d/k c2, in whichk d is the rate constant for the spontaneous dismutation reaction and k c is the rate constant for the reduction of cytochrome c by O⨪2. The factork d/k c2 provided a means for correcting for the small fraction of O⨪2 that undergoes spontaneous dismutation before the O⨪2 can reduce cytochrome c. The rates of generation of O⨪2, as measured by the rate of cytochrome c reduction, were similar whether catalase (2 μm) was present or absent. At pH 7.4 and 37 °C, the xanthine oxidase had an average specific activity of 115 μmol min−1 per μmol of enzyme. The total rate of production of H2O2 by xanthine oxidase was determined from the rate of production of urate, as measured by the rate of increase in absorbance at 295 nm (), and was confirmed with the assay for H2O2 of Green and Hill () on incubations containing xanthine oxidase, xanthine, and superoxide dismutase. The rate of oxidation of NADPH was determined from the amount of 6-phosphogluconate formed, as described previously (12
). All reaction mixtures had a final volume of 1.0 ml. All incubations were at pH 7.4 and 37 °C except for one experiment in which the conditions were otherwise stated. The reaction components were at the final concentrations indicated within parentheses when the concentrations were not specified and were as follows: catalase and, when present, xanthine oxidase, xanthine (100 μm), superoxide dismutase, NADP+ (2 μm), glucose 6-phosphate (1 mm), glucose-6-phosphate dehydrogenase (10 μg/ml), glucose (5 mm).For following the kinetics of reactions, readings of absorbance from the spectrophotometer were taken on each group of cuvettes at intervals of 1 min per group and were automatically stored in a computer for later statistical analysis. For obtaining spectra of catalase, absorbance readings were taken and stored at intervals of 1 nm. The absorption spectra were obtained with a Beckman DU-7 spectrophotometer at a recording speed of 1,200 nm min−1. Prof. Peter Nicholls kindly provided the absorbances of equimolar concentrations of ferricatalase (the resting or free form of catalase) and compounds I, II, and III at intervals of 1 nm between 350 and 750 nm. The plots from these absorbances were similar to previously published spectra (
22
,). The spectra for ferricatalase, compound I, and compound II were confirmed in the following manner. One ml of 100 mmpotassium Ches buffer, pH 8.6, was added to 0.5 ml of the bovine liver catalase from the bottle (20 mg/ml) to dissolve all enzyme crystals. The dissolved enzyme was further diluted in 50 mm Na-K phosphate buffer, pH 6.5, to a concentration of about 10 μm. One ml of enzyme preparation was then transferred to a cuvette. After a preincubation period of 5 min at 37 °C, the spectrum of ferricatalase was obtained. After the first spectrum was obtained, 5 μl of 3% peracetic acid were added to the cuvette, and the spectrum was immediately re-determined (compound I). One microliter of 60 mm potassium ferrocyanide was then added to the same reaction mixture, and after 10 min of incubation at 37 °C, the spectrum was determined again (compound II). The absorbances of equimolar concentrations of the four forms of catalase were used to determine the amount of each form in H2O-treated catalase by a least squares method, as follows. The minimum was found for the sum (from 501 to 750 nm) of the squares of the difference betweenU n andf f A n +f I B n +f II C n +f III D n, in which nis the wavelength, U n is the absorbance of the treated catalase at wavelength n, andf f through f III represent the unknown fractions of the treated catalase that are in the form of ferricatalase, compound I, etc. A n throughD n represent the known absorbances of equimolar concentrations of ferricatalase through compound III at wavelengthn. The value for each f was obtained from the solution of the resulting simultaneous, linear equations for thefs. A visual check of the validity of the result was obtained with a spreadsheet/graphing program that allowed a comparison of the observed spectrum with the spectrum from any specified combination of the four forms of catalase. The formation of compound II is usually followed at 435 nm, the isosbestic point between ferricatalase and compound I (22
). The difference in extinction coefficient between ferricatalase and compound II was considered to be 32 mm−1 cm−1 (31
). As observed also by Chance (), the extinction coefficient of compound III at 435 nm was found to be similar to that of compound II. The increases in absorbance at 435 nm were therefore considered to represent the combined rate of formation of both compounds.Acknowledgments
We thank Prof. Peter Nicholls for providing the absorption spectra of equimolar concentrations of the four forms of bovine liver catalase as well as for suggestions on converting the enzyme to compounds I, II, and III.
REFERENCES
- FEBS Lett. 1991; 281: 9-19
- Science. 1996; 273: 59-63
- J. Lab. Clin. Med. 1992; 119: 598-620
- Science. 1961; 134: 1756-1757
- J. Clin. Invest. 1965; 44: 1187-1199
- Proc. Natl. Acad. Sci. U. S. A. 1974; 71: 3584-3587
- J. Lab. Clin. Med. 1991; 118: 7-16
- Biochim. Biophys. Acta. 1993; 1181: 163-168
- Blood. 1994; 84: 325-330
- Blood. 1996; 87: 1595-1599
- Proc. Natl. Acad. Sci. U. S. A. 1984; 81: 4343-4347
- J. Biol. Chem. 1987; 262: 660-666
- Arch. Biochem. Biophys. 1986; 248: 71-79
- Adv. Exp. Med. Biol. 1972; 28: 121-131
- Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 1604-1608
- FEBS Lett. 1992; 314: 179-182
- Biochem. J. 1994; 300: 531-539
- J. Am. Chem. Soc. 1993; 115: 7093-7102
- Biochemistry. 1995; 34: 7335-7347
- Nat. Struct. Biol. 1996; 3: 951-956
- Free Radical Res. 1995; 22: 251-274
- Boyer P.D. Lardy H. Myrback K. The Enzymes. Academic, New York1963: 147-225
- J. Biol. Chem. 1982; 257: 5751-5754
- J. Biol. Chem. 1951; 193: 265-275
- Methods Enzymol. 1984; 105: 121-126
- Methods Enzymol. 1984; 105: 3-22
- J. Biol. Chem. 1969; 244: 6049-6055
- Biochim. Biophys. Acta. 1973; 327: 257-265
- J. Biol. Chem. 1970; 245: 4053-4057
- Arch. Biochem. Biophys. 1952; 41: 404-415
- Int. J. Radiat. Biol. 1989; 55: 45-50
- J. Phys. Chem. 1968; 72: 3836-3841
- Biochem. J. 1950; 46: 387-402
- Biochim. Biophys. Acta. 1995; 1252: 172-176
- J. Mol. Biol. 1995; 249: 933-954
- Biochemistry. 1997; 36: 9356-9364
Article Info
Publication History
Published online: May 14, 1999
Received:
February 16,
1999
Identification
Copyright
© 1999 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
User License
Creative Commons Attribution (CC BY 4.0) | How you can reuse
Elsevier's open access license policy
Creative Commons Attribution (CC BY 4.0)
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy





